Dark Mode Light Mode

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Follow Us
Follow Us

Philadelphia researchers call New Alzheimer’s blood tests promising.

Spread the love


Philly and PA. Why do you want to deal with the news, from suburbs to South Jersey and Delaware? Please let me know!

Medical service providers hope for a new blood test Alzheimer’s bottle It will lead to faster and early diagnosis of progressive form. idiotThis affects almost 500,000 people in three states.

The Lumipulse blood test has become the first “diagnostic device in the test” approved by the US Food and Pharmacy. I took it Earlier this month as a new tool for diagnosing Alzheimer’s disease.

Federal and local health experts have aged with the entire population and more people Sign.

Brian Balin, a researcher at the Philadelphia College of Osteopathic Medicine, said, “I think this can be very good at the beginning to get a better diagnosis.” So, plan there.

More than 480,000 people aged 65 or older live with Alzheimer’s disease in Delaware, New Jersey and Pennsylvania. Federal estimation.

Although there is no treatment, early diagnosis can provide patients with the opportunity to start treatment and drugs that can be helpful. Symptoms Experts speak like nursery rhyme and depression.

The latest treatment including the same drug This is And KISUNLA aims to slow down the disease by removing the amyloid plaque of the brain, which is characterized by Alzheimer’s, but the drug is still being studied and provided in terms of their effectiveness. Side effects and high price tags.

The new blood test measures two subtypes of tau and amyloid proteins. According to clinical trials, certain levels of these proteins in the blood can be “stably predicted” the presence of amyloid plaque in the brain.

Brain imaging, such as PET scan using radiation, can identify amyloid plaque, but FDA officials hope that blood tests can act as a less invasive and less expensive option.

Balin, the director of the chronic disorder center of aging on the PCM, said that the provider should pay attention when relying on blood tests, which may seem to have increased in the blood for reasons other than Alzheimer’s, including brain damage and Parkinson’s disease.



Source link

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Add a comment Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

GLP-1 Drug Environment changes on Thursday

Next Post

The anti malaria, which is absorbed by the mosquito foot, kills parasites and causes stops transmission.